title: [Review of the 2016 Swiss immunization schedule and technology update for improving vaccine management].
abstract: The 2016 immunization schedule published by the Swiss Federal Office of Public Health includes three new clauses: reimbursement of the additional Human Papillomavirus (HPV) vaccination in young males (11-26 years) as recommended by local canton programs, the end of franchise exemption for the measles, mumps and rubella (MMR) vaccination, and the creation of a new system of indemnities and moral compensation in the event of personal injury resulting from vaccinations. This article presents the main features of the 2016 immunization schedule with details of the technology available to physicians to improve vaccine management.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Diana
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000191:economics* / Q000639:trends; D007115:Immunization Schedule; D008297:Male; D032541:Mass Vaccination / Q000191:economics; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000191:economics; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage / Q000191:economics*; D030361:Papillomavirus Infections / Q000191:economics* / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000191:economics*; D011008:Pneumococcal Infections / Q000191:economics / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000191:economics*; D011634:Public Health / Q000191:economics* / Q000639:trends; D012409:Rubella / Q000517:prevention & control; D012411:Rubella Vaccine / Q000191:economics; D013557:Switzerland; D014611:Vaccination / Q000191:economics*
chemical_list: D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D053918:Papillomavirus Vaccines; D022242:Pneumococcal Vaccines; D012411:Rubella Vaccine